AMBS News Amarantus BioSciences Corporate Overview
Post# of 144840
AMBS News Amarantus BioSciences Corporate Overview to be Webcast Live Today from OneMedForum 2012 Conference in NYC
2012-07-12 10:53 ET - News Release
SUNNYVALE, Calif., July 12, 2012 /PRNewswire/ -- Amarantus BioSciences, Inc. (OTCBB: AMBS), a biotechnology company developing new treatments for human disorders including Parkinson's disease and Traumatic Brain Injuries (TBI) centered on its proprietary anti-apoptotic therapeutic protein known as MANF, today announced that its President & CEO Gerald E. Commissiong will be presenting a corporate overview today, July 12th, 2012, to be broadcast live from OneMedForum 2012 Conference at 11:20am ET from the Metropolitan Club in New York City. To watch the webcast live, click on the link http://www.onemedplace.com/forum/webcast/ .
EVENT INFORMATION AT A GLANCE:
WHO: Gerald Commissiong, President and Chief Executive Officer
WHEN: July 12th, 2012 at 11:20am ET
WHERE: Metropolitan Club, New York City
(0)
(0)